In January 2010 BÜHLMANN starts the distribution of the innovative diagnostic products of BioPorto in
NGAL begins to rise within an hour of AKI, whereas current diagnostic methods only detect the consequences of damage well after the event.
The NGAL product portfolio of BioPorto contains a rapid CE marked ELISA allowing a raised level of NGAL to be rapidly determined in urine or plasma sample. For research samples the slower but more sensitive ELISA is to be preferred. For pharmaceutical animal research BioPorto is offering three different ELISA variants for mouse, rat or dog samples.